News Quantified

SAVA – cassava sciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Cassava Announces Agreement to Settle Securities Class Action Litigation

Cassava Sciences rises 10% after market close on CEO stock buy [Seeking Alpha]

Cassava Reports Q3 2025 Financials Results and Provides Business Update

Cassava Sciences (NASDAQ:SAVA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

3.3%

BEAT

3.3%

BEAT

2.9%

BEAT

2.5%

BEAT

Form 8-K CASSAVA SCIENCES INC For: Dec 19

Form 8-K/A CASSAVA SCIENCES INC For: Oct 21

Form 8-K CASSAVA SCIENCES INC For: Dec 15

Form 8-K CASSAVA SCIENCES INC For: Dec 12

Form EFFECT CASSAVA SCIENCES INC

Top News Gainers

12/20 Form 4 CASSAVA SCIENCES INC For: Dec 20 Filed by: ROBERTSON SANFORD 60.3%

12/31 Form 4 CASSAVA SCIENCES INC For: Dec 31 Filed by: BARBIER REMI 37.1%

4/23 Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health 32.9%

12/26 Form 4/A CASSAVA SCIENCES INC For: Dec 18 Filed by: BARBIER REMI 29.3%

1/28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease 20.8%

9/3 Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference 17.9%

12/19 Form 4 CASSAVA SCIENCES INC For: Dec 19 Filed by: ROBERTSON SANFORD 17.5%

3/19 Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline 17.2%

4/9 Form S-3/A CASSAVA SCIENCES INC 16.5%

1/15 Cassava Sciences Inc (NASDAQ: SAVA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 14.5%

Top News Decliners

12/6 Cassava Sciences Inc (NASDAQ: SAVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $3.00. -21.8%

9/9 Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients -15.9%

1/6 Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock? [Yahoo! Finance News] -9.6%

1/7 Form SC 13G/A CASSAVA SCIENCES INC Filed by: HIRSCHMAN ORIN -9.4%

6/25 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. -8.5%

1/24 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -8.0%

8/1 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock. -7.6%

8/12 Q2/2019 6/30/2019 EPS -0.060 ZacksConsensus -0.120 ActVsEst 0.060 - Beat -6.8%

3/27 Form S-3 CASSAVA SCIENCES INC -5.2%

10/19 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day